A further study showed that 19.7% of patients with COVID‐19 presented with myocardial injury diagnosed by elevated cTnI, and had a significantly higher mortality rate compared to patients with normal cTnI levels, 51.2% vs 4.5%, illustrating the potential prognostic value of cTnI.13 The gene discussed is TNNI3; the disease is COVID-19.